Health

Moderna says it will “never” patent Covid-19 vaccine in dozens of low- and middle-income countries

In countries outside the 92 group, the company “expects those who use Moderna’s patented technologies to respect the company’s intellectual property,” the statement said. “Moderna is still ready to license its technology to manufacturers of COVID-19 vaccines in these countries on commercially reasonable terms.

Moderna also announced Monday that it has signed a memorandum of understanding with the Kenyan government to host an mRNA production facility that aims to produce 500 million doses of the vaccine a year. It will also expand its global public health portfolio to 15 vaccine programs targeting developing or neglected infectious diseases, and will launch a program that will allow researchers to use Moderna mRNA technology to search for new vaccines against these diseases.

When the United States and other rich countries began looking for ways to overcome the pandemic, only 65 percent of the world’s population received at least one dose of the Covid-19 vaccine. უ New York TimesVaccine tracker. In Africa, only 11 percent of the population was fully vaccinated as of February WHOBecause countries face obstacles in distributing vaccine doses.

In June 2021, the World Health Organization selected a South African consortium to operate a Global mRNA Transfer Technology Center designed to assist manufacturers in low- and middle-income countries in producing their own Covid-19 vaccines and, more broadly, in producing their own vaccines. Medications and supplies, instead of relying on Western firms.

Although South Africa is not one of the AMC 92 countries, Moderna says it will allow the WHO center and Afrigen BiologicsA company based in Cape Town trying to replicate the Moderna vaccine for the hub, accessing its technology for vaccines targeted at a specified group of nations.

“In keeping with this promise, Moderna will not pursue its patent for COVID-19 vaccines in South Africa against the efforts of Afrigen Biologics and / or the WHO Center for AMC 92 countries,” a Moderna spokeswoman told POLITICO on Monday. .

Moderna says it will “never” patent Covid-19 vaccine in dozens of low- and middle-income countries

Source link Moderna says it will “never” patent Covid-19 vaccine in dozens of low- and middle-income countries

Back to top button